Follow
MARCOS GONZÁLEZ DÍAZ
MARCOS GONZÁLEZ DÍAZ
Servicio de Hematología, Hospital Universitario, Salamanca Spain
Verified email at usal.es
Title
Cited by
Cited by
Year
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report …
JJM Van Dongen, AW Langerak, M Brüggemann, PAS Evans, M Hummel, ...
Leukemia 17 (12), 2257-2317, 2003
36002003
International network of cancer genome projects
Data coordination centre Kasprzyk (Leader) Arek 1 Stein (Leader) Lincoln D ...
Nature 464 (7291), 993-998, 2010
22472010
Standardization and quality control studies of ‘real-time’quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection …
J Gabert, E Beillard, VHJ Van der Velden, W Bi, D Grimwade, ...
Leukemia 17 (12), 2318-2357, 2003
19012003
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ...
Nature 475 (7354), 101-105, 2011
18732011
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
JJM Van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, ...
Leukemia 13 (12), 1901-1928, 1999
15341999
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
V Quesada, L Conde, N Villamor, GR Ordóñez, P Jares, L Bassaganyas, ...
Nature genetics 44 (1), 47-52, 2012
12342012
Non-coding recurrent mutations in chronic lymphocytic leukaemia
XS Puente, S Beà, R Valdés-Mas, N Villamor, J Gutiérrez-Abril, ...
Nature 526 (7574), 519-524, 2015
9832015
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA …
MA Sanz, FL Coco, G Martın, G Avvisati, C Rayón, T Barbui, ...
Blood, The Journal of the American Society of Hematology 96 (4), 1247-1253, 2000
8102000
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA …
MA Sanz, G Martín, M González, A León, C Rayón, C Rivas, D Colomer, ...
Blood 103 (4), 1237-1243, 2004
6082004
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, ...
Leukemia 31 (10), 2094-2103, 2017
5862017
A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR-Positive Acute …
MA Sanz, G Martı́n, C Rayón, J Esteve, M González, J Dı́az-Mediavilla, ...
Blood, The Journal of the American Society of Hematology 94 (9), 3015-3021, 1999
5401999
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
531*2021
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
J Martinez-Lopez, JJ Lahuerta, F Pepin, M González, S Barrio, R Ayala, ...
Blood, The Journal of the American Society of Hematology 123 (20), 3073-3079, 2014
4962014
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics
R Garcıa-Sanz, A Orfao, M Gonzalez, MD Tabernero, J Bladé, MJ Moro, ...
Blood, The Journal of the American Society of Hematology 93 (3), 1032-1037, 1999
4531999
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment …
JF San Miguel, MB Vidriales, C López-Berges, J Dıaz-Mediavilla, ...
Blood, The Journal of the American Society of Hematology 98 (6), 1746-1751, 2001
4282001
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
J De La Serna, P Montesinos, E Vellenga, C Rayón, R Parody, A León, ...
Blood, The Journal of the American Society of Hematology 111 (7), 3395-3402, 2008
4242008
Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and …
MJ Pongers-Willemse, T Seriu, F Stolz, E d’Aniello, P Gameiro, P Pisa, ...
Leukemia 13 (1), 110-118, 1999
4201999
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome …
P Montesinos, JM Bergua, E Vellenga, C Rayón, R Parody, J De La Serna, ...
Blood, The Journal of the American Society of Hematology 113 (4), 775-783, 2009
3812009
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
F Nadeu, J Delgado, C Royo, T Baumann, T Stankovic, M Pinyol, P Jares, ...
Blood, The Journal of the American Society of Hematology 127 (17), 2122-2130, 2016
3622016
Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
S Beà, M Ribas, JM Hernández, F Bosch, M Pinyol, L Hernández, ...
Blood, The Journal of the American Society of Hematology 93 (12), 4365-4374, 1999
3611999
The system can't perform the operation now. Try again later.
Articles 1–20